The paper presents the results obtained in the treatment of 510 patien
ts with noninsulin-dependent diabetes mellitus (NIDDM). Of them 420 re
ceived bucarban, 30 gilemal and 60 adebit. Bucarban and gilemal decrea
sed fasting glycemia and that after the standard meal. The patients we
re also made less insulin-resistant. Hyperinsulinemia did not respond
to the above drugs. Adebit demonstrated hypoglycemic, antihyperinsulin
emic, antihyperbetalipoproteinemic and hypocholesterolemic activity. 1
0% of NIDDM patients developed primary resistance to oral sulfonamide
drugs. In intact insulin secretion NIDDM patients were effectively tre
ated both with sulfonamide sugar-reducing drugs and biguanid derivativ
es.